Hart recently published an article summarising the results of a study performed in the US military which found that nearly 3% of those vaccinated with smallpox vaccine developed subclinical myocarditis (defined by an increased troponin level – which was prospectively measured in all subjects).
We, the undersigned, are writing to express our deep concern at the guidance regarding further mRNA vaccination after any episode of myocarditis, as detailed in the UKHSA guidance for healthcare professionals.
In 2015 a team of researchers employed by the medical services of the US military published a peer-reviewed paper on the incidence of myocarditis and pericarditis after smallpox vaccination (SPX) and vaccination with an inactivated trivalent influenza vaccine (TIV).
Two new studies on myocarditis / pericarditis after mRNA vaccination have been published in major peer-reviewed journals.
Both are based on very large population samples. Both these studies find significantly higher rates of myocarditis, especially in younger males, than governments have to date acknowledged publicly.
The official narrative claims that vaccines prevent infection and therefore reduce risk of myocarditis from infection. This claim is reliant on two points: 1. Vaccines reducing infections 2. That infection related myocarditis occurs at a lower rate in the vaccinated.
The rise in ambulance calls for cardiac and respiratory arrests suggests that people are right in their suspicions and that there are good reasons for genuine concern about the health of the nation’s hearts.